Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

CELGZ:US

2.1601 USD 0.0699 3.13%

As of 20:10:00 ET on 05/28/2015.

Snapshot for Celgene Corp (CELGZ)

Open: 2.2300 Day's Range: 2.1000 - 2.2400 Volume: 40,431
Previous Close: 2.2300 52wk Range: 2.1000 - 3.8300 1-Yr Rtn: -18.49%

Stock Chart for CELGZ

No chart data available.
  • CELGZ:US 2.1601
  • 1D
  • 1M
  • 1Y
2.2300
Interactive CELGZ Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CELGZ

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 0.00
Shares Outstanding (M) 43.00
30 Day Average Volume 12,515
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 6.9326
Dividend Ex-Date 10/08/2013
5 Year Dividend Growth -
Next Earnings Announcement 07/24/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CELGZ

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CELGZ

Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.

Robert J Hugin "Bob"Chief Executive OfficerMark J AllesPresident/COO
Perry A KarsenCEO:Celgene Cellular TherpeuticsThomas O DanielPres:Research & Early Dev
More Company Profile & Key Executives for CELGZ

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil